The Enterprise Value as of December 2025 (TTM) for Alumis Inc. Common Stock (ALMS) is 839.07M

According to Alumis Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 839.07M. This represents a change of 18.60% compared to the average of 707.47M of the last 4 quarters.

Alumis Inc. Common Stock (ALMS) Historical Enterprise Value (quarterly & annually)

How has ALMS Enterprise Value performed in the past?

The mean historical Enterprise Value of Alumis Inc. Common Stock over the last ten years is 278.59M. The current 839.07M Enterprise Value has changed 30.02% with respect to the historical average. Over the past ten years (40 quarters), ALMS's Enterprise Value was at its highest in in the December 2024 quarter at 2.09B. The Enterprise Value was at its lowest in in the June 2023 quarter at 0.

Alumis Inc. Common Stock (ALMS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alumis Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alumis Inc. Common Stock (ALMS) Average Enterprise Value

How has ALMS Enterprise Value performed in the past?

The current Enterprise Value of Alumis Inc. Common Stock (ALMS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Alumis Inc. Common Stock (ALMS) Enterprise Value vs. Peers

How is ALMS’s Enterprise Value compared to its peers?

Alumis Inc. Common Stock’s Enterprise Value is greater than RAPT Therapeutics, Inc. (534.71M), greater than Neumora Therapeutics, Inc. Common Stock (251.41M), greater than ADC Therapeutics S.A. (262.56M), greater than Ocugen, Inc. (393.09M), greater than Eton Pharmaceuticals, Inc. (416.94M), less than Omeros Corporation (883.69M), greater than Fulcrum Therapeutics, Inc. (433.95M), greater than Lexicon Pharmaceuticals, Inc. (556.11M), greater than Bicycle Therapeutics plc (-152624053.00), greater than Lineage Cell Therapeutics, Inc. (362.42M),

Build a custom stock screener for Alumis Inc. Common Stock (ALMS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alumis Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alumis Inc. Common Stock (ALMS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alumis Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.